Daiken Medical Balance Sheet

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Cash & Equivalents	2,384	2,995	2,739	2,516	2,518	2,170
Cash & Short-Term Investments	2,384	2,995	2,739	2,516	2,518	2,170
Cash Growth	-19.85%	9.35%	8.86%	-0.08%	16.04%	-8.24%
Receivables	2,812	2,471	2,479	2,530	2,431	2,587
Inventory	1,461	1,430	1,438	1,514	1,544	1,421
Prepaid Expenses	-	42	24	18	19	23
Other Current Assets	174.25	47	50	60	60	71
Total Current Assets	6,831	6,985	6,730	6,638	6,572	6,272
Property, Plant & Equipment	4,014	3,931	3,986	4,070	4,119	4,225
Long-Term Investments	-	68	70	65	53	67
Other Intangible Assets	11.03	12	13	9	15	21
Long-Term Deferred Tax Assets	188.66	183	205	230	160	166
Other Long-Term Assets	66.24	2	2	1	1	1
Total Assets	11,111	11,181	11,006	11,013	10,920	10,752
Accounts Payable	529.66	1,027	1,066	1,117	1,004	957
Accrued Expenses	92.63	69	65	70	70	179
Short-Term Debt	920	746	1,114	1,058	1,019	1,033
Current Portion of Long-Term Debt	390.04	480	389	659	597	704
Current Portion of Leases	-	4	8	9	11	11
Current Income Taxes Payable	94.1	484	671	428	427	259
Other Current Liabilities	822.41	19	26	28	23	204
Total Current Liabilities	2,849	2,829	3,339	3,369	3,151	3,347
Long-Term Debt	540.9	818	623	1,013	1,280	1,177
Long-Term Leases	-	3	8	16	26	28
Other Long-Term Liabilities	25	16	14	19	18	18
Total Liabilities	3,415	3,666	3,984	4,417	4,475	4,570
Common Stock	495.88	495	495	495	495	495
Additional Paid-In Capital	400.88	400	400	400	400	400
Retained Earnings	8,594	8,414	7,920	7,506	7,368	7,112
Treasury Stock	-1,827	-1,826	-1,826	-1,826	-1,826	-1,826
Comprehensive Income & Other	31.38	32	33	21	8	1
Shareholders' Equity	7,696	7,515	7,022	6,596	6,445	6,182
Total Liabilities & Equity	11,111	11,181	11,006	11,013	10,920	10,752
Total Debt	1,851	2,051	2,142	2,755	2,933	2,953
Net Cash (Debt)	532.58	944	597	-239	-415	-783
Net Cash Growth	-15.87%	58.12%	-	-	-	-
Net Cash Per Share	18.54	32.86	20.78	-8.32	-14.45	-27.26
Filing Date Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Total Common Shares Outstanding	28.73	28.73	28.73	28.73	28.73	28.73
Working Capital	3,982	4,156	3,391	3,269	3,421	2,925
Book Value Per Share	267.89	261.59	244.43	229.60	224.34	215.19
Tangible Book Value	7,685	7,503	7,009	6,587	6,430	6,161
Tangible Book Value Per Share	267.50	261.17	243.97	229.29	223.82	214.46

Source: S&P Global Market Intelligence. Standard template. Financial Sources.